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Regulated SUMOylation and Ubiquitination of DdMEK1
Is Required for Proper Chemotaxis
MEK1S444A,T448A, which cannot be activated, does not com-
plement the null mutation and functions as a dominant
interfering (negative) protein when expressed in wild-
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University of California, San Diego type cells. Studies examining the phenotypes of a tem-
perature-sensitive allele of MEK1 suggest that MEK1 is9500 Gilman Drive
La Jolla, California 92093 required at the time of chemoattractant-mediated stimu-
lation to control chemotaxis (Ma et al., 1997). Recent
studies indicate that embryonic fibroblasts from mek1/
or mekk1/ mice have defects in cell migration, sug-
Summary gesting that this function could be evolutionarily con-
served between Dictyostelium and vertebrate MAP ki-
MEK1, which is required for aggregation and chemo- nase pathways (Giroux et al., 1999; Yujiri et al., 2000).
taxis in Dictyostelium, is rapidly and transiently SU- SUMO is a ubiquitin-related protein that, like ubiquitin,
MOylated in response to chemoattractant stimulation. is covalently attached to a lysine residue on the sub-
SUMOylation is required for MEK1’s function and its strate protein via a pathway similar to ubiquitination
translocation from the nucleus to the cytosol and cor- (Hochstrasser, 2001; Melchior, 2000; Muller et al., 2001;
tex, including the leading edge of chemotaxing cells. Bernier-Villamor et al., 2002). SUMOylation has been
MEK1 in which the site of SUMOylation is mutated is implicated in the control of subcellular protein localiza-
retained in the nucleus and does not complement the tion and/or proteasomal degradation of several sub-
mek1 null phenotype. Constitutively active MEK1 is strate proteins (reviewed in Muller et al., 2001). For ex-
cytosolic and is constitutively SUMOylated, whereas ample, SUMOylation can oppose ubiquitination and
the corresponding nonactivatable MEK1 is not SUMO- proteasomal degradation by competitive attachment to
ylated and nuclear. MEK1 is also ubiquitinated in re- the same lysine residues within substrate proteins, as
sponse to signaling. A MEK1-interacting, ubiquitin E3 is the case for IB (Desterro et al., 1998) and MDM2
ligase RING domain-containing protein controls nuclear (Buschmann et al., 2000).
localization and MEK1 ubiquitination. These studies pro- In this manuscript, we demonstrate that Dictyostelium
vide a pathway regulating the localization and function MEK1 is SUMOylated in response to chemoattractant
of MEK1. stimulation and that this modification plays a central
role in regulating MEK1’s subcellular localization and
function. MEK1 is also ubiquitinated and the level ofIntroduction
polyubiquitinated MEK1 increases in response to che-
moattractant stimulation, with kinetics that are delayedChemotaxis, a form of directed cell movement, is a basic
compared to those of SUMOylation. We identified theproperty exhibited by many motile cells and can be
MEK1-interacting protein MIP1 and present genetic andstimulated by chemoattractants that bind to and acti-
biochemical evidence that MIP1 functions as a MEK1-vate pathways downstream from G protein-coupled re-
specific E3 ubiquitin ligase and controls MEK1’s nuclearceptors and receptor protein tyrosine kinases. Recent
localization. These results provide new insights into thestudies have demonstrated that signaling pathways that
mechanisms controlling chemotaxis and the differentialcontrol chemotaxis are highly conserved in diverse cell
role of the SUMOylation and ubiquitination pathways intypes, including leukocytes, fibroblasts, and Dictyostel-
controlling subcellular localization and the regulation ofium amoebae (Chung et al., 2001; Parent and Devreotes,
MAP kinase cascades.1999; Rickert et al., 2000).
In Dictyostelium, a MAP kinase cascade was pre-
viously identified that is required for chemotaxis toward Results
cAMP, the chemoattractant that mediates the aggrega-
tion response, leading to the formation of a multicellular Dictyostelium MEK1 Is Transiently SUMOylated
in Response to Chemoattractant Stimulationorganism (Ma et al., 1997). Null mutants of the Dictyostel-
ium MAP kinase kinase MEK1 are unable to properly We examined whether Dictyostelium MEK1 is transiently
modified in response to chemoattractant stimulation bychemotax and form extremely small aggregates, pre-
sumably through cell-cell adhesion contacts rather than expressingFLAG- or myc-tagged versions of MEK1 in either
mek1 null (Ma et al., 1997) or wild-type cells (strain KAx-3).chemoattractant-mediated aggregation. A constitutively
active MEK1 (MEK1S444E,T448E) in which the serine and thre- Expression of either tagged MEK1 complemented the
mek1 null phenotypes and produced indistinguishableonine phosphorylation sites in the activation loop are
mutated to glutamate complements the mek1 null cell results (Figures 1B and 1C; data for myc-tagged MEK1
is not shown). Upon stimulation of “aggregation-compe-chemotaxis defect, but this strain is unable to undergo
proper morphogenesis upon reaching the mound stage. tent” Dictyostelium cells by the chemoattractant cAMP,
there is a transient shift of the mobility of a portion of
MEK1 from an apparent molecular weight of75 to901Correspondence: rafirtel@ucsd.edu
kDa on SDS-PAGE gels (Figure 1A). The maximal shift2 Present address: Salk Institute for Biological Sciences, 10010 North
Torrey Pines Road, La Jolla, California 92037. occurs between 5 and 15 s (15 s time point is shown)
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Figure 1. MEK1 SUMOylation and Its Role in Aggregation and Chemotaxis
(A) MEK1 is SUMOylated on K105. mek1 null cells coexpressing HA-DdSUMO and either MEK1-FLAG (left panel) or MEK1K105R-FLAG (right
panel) were pulsed every 6 min with 30 nM cAMP for 5 hr, stimulated with 30 M cAMP for the indicated time intervals, and lysed as described
in Experimental Procedures. Immunoprecipitated MEK1 was subjected to immunoblot analysis with anti-FLAG and anti-HA antibodies.
(B) The morphology of mek1, erk1, and mek1 cells expressing either MEK1-FLAG or MEK1K105R-FLAG at the aggregation stage of development.
(C) Chemotaxis of wild-type cells, mek1 and erk1 null cells, and mek1 null or wild-type KAx-3 cells expressing MEK1K105R. Time-lapse recording
and quantitative analysis showing the chemotaxis defects of cells moving toward a pipette filled with 150 M cAMP. Superimposed images
show the cell shapes, direction, and length of the path during chemotaxis at 1 min intervals. When mek1 null cells are pulsed for a longer
time (see Experimental Procedures), the cells become more polarized but still exhibit significant chemotaxis defects (data not shown.) The
strain names and genotypes are given in the table. All strains have been made in the KAx-3 wild-type background.
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after stimulation and then decreases to background lev- proper MEK1 function. Expression of MEK1K105R in wild-
type cells resulted in chemotaxis defects that were simi-els by 1–3 min. As shown in Figure 1, there is a very low
lar to those of mek1/MEK1K105R cells (Figure 1C), consis-basal level of the 90 kDa isoform of MEK1 in unstimu-
tent with the aggregation defect exhibited by this strain.lated cells, presumably due to the repetitive cycles of
cAMP stimulation used to maximally express compo-
MEK1 Translocates to the Cell Cortex in Responsenents of the signaling pathway to make cells responsive
to Chemoattractant Stimulation and Is Foundto cAMP (“aggregation-competent” cells).
at the Leading Edge of Chemotaxing CellsThe observation of a major molecular species shifted
Since GFP-tagged MEK1 (placed at either the N or Cby 15 kDa and the presence of putative SUMOylation
terminus) did not effectively complement the mek1 nullconsensus sites (I/LKXE; Sampson et al., 2001; Bernier-
phenotype, we examined the subcellular localization ofVillamor et al., 2002) in MEK1 (MEK1K70 and MEK1K105)
MEK1 using FLAG-tagged MEK1 expressed in mek1 nullsuggested that MEK1 might be SUMOylated. We tested
or wild-type cells by indirect immunofluorescence usingthis hypothesis by coexpressing Dictyostelium MEK1-
deconvolution microscopy and analyzed the data withFLAG and HA-tagged Dictyostelium SUMO (GenBank
SoftWorx software (Agard et al., 1989). In unstimulated,accession number AF446008; see Experimental Proce-
aggregation-competent cells or vegetatively growingdures). The MEK1-FLAG was immunoprecipitated with
cells, FLAG-tagged MEK1 was found predominantly inan anti-FLAG antibody and the blot was probed with
the nucleus (Figures 2A and 2B). Upon cAMP stimulationeither an anti-FLAG or anti-HA antibody. An 90 kDa
of aggregation-competent cells, a portion of MEK1 tran-band was detected by both the anti-FLAG and anti-HA
siently translocated to the cytosol and cell cortex. Theantibodies (Figure 1A). This band had the same mobility
timing of this change in MEK1 subcellular localizationas that identified with an anti-human SUMO antibody
was similar to that of MEK1 SUMOylation, with maximal(data not shown; see below).
cortical and cytoplasmic localization at 5 to 15 s afterTo examine whether K70 or K105 is the site of SUMO-
stimulation (Figures 2A, 2B, 2E, and 2F). Quantitativeylation, we expressed in wild-type cells MEK1 in which
analysis of fluorescence intensities (Figure 2F) revealedthese lysines were individually mutated to arginines, and
a significant increase of MEK1 concentration in the cellchemoattractant-mediated SUMOylation was examined.
cortex at 15 s after stimulation. There is a concomitantMEK1K105R was not SUMOylated (Figure 1A), whereas
decrease in nuclear MEK1 (see below). By 3 min, theMEK1K70R was SUMOylated (data not shown), indicating
level of cortical localization was significantly reduced.that K105 is the site of MEK1 SUMOylation. To examine
In chemotaxing cells, FLAG-MEK1 is highly enriched atthe biological consequences of MEK1 SUMOylation, we
the leading edge, colocalizing with F-actin (Figure 2D).
expressed MEK1K105R in mek1 null and wild-type cells
Figure 2A shows that a fraction of HA-tagged SUMO
(strain KAx-3). Time-lapse video microscopy and im-
colocalized with FLAG-tagged MEK1 in the areas of the
aging of the development of mek1 null cells expressing
cell cortex after chemoattractant stimulation. This result
FLAG- or myc-tagged MEK1K105R revealed that MEK1K105R was further confirmed using the anti-SUMO antibody
was unable to properly complement the mek1 null phe- (data not shown). Both MEK1 and SUMO proteins dis-
notype; this strain produced significantly smaller aggre- played similar kinetics of cortical localization, consistent
gates than wild-type cells, although the size of the ag- with cortically localized SUMO being, at least in part,
gregates was larger than those of mek1 null cells (Figure conjugated to MEK1, although we cannot rule out the
1B; data for time-lapse microscopy not shown). Many possibility that we are also visualizing SUMO conjugated
mek1/MEK1K105R cells fail to enter the aggregates, ap- to other proteins. To determine whether SUMOylation
parently due to chemotaxis defects (see below). Wild- may be required for this change in MEK1 localization, we
type cells expressing MEK1K105R also produced small examined the subcellular localization of FLAG-MEK1K105R
aggregates, indicating that SUMOylation-deficient expressed in either mek1 null or wild-type cells. Quanti-
MEK1K105R functions as a dominant-negative protein. tative analysis shows that, like wild-type FLAG-MEK1,
To confirm that mek1/MEK1K105R cells are defective FLAG-MEK1K105R is predominantly nuclear in unstimu-
in chemotaxis, we examined the ability of mek1 null cells, lated cells; however, in contrast to wild-type MEK1,
wild-type cells, mek1/MEK1K105R cells, and wild-type cells MEK1K105R does not exhibit a significant increase of corti-
expressing MEK1K105R (KAx-3/MEK1K105R) to chemotax to- cal localization in response to cAMP stimulation (Figures
ward a micropipette containing cAMP (Chung and Firtel, 2C and 2F). These results are consistent with SUMOyla-
1999; Meili et al., 1999). Whereas wild-type cells rapidly tion being required for MEK1 translocation. The inability
chemotax toward a micropipette emitting cAMP and of MEK1K105R to localize at the plasma membrane may
produce few lateral pseudopodia (Figure 1C), mek1 null be, at least in part, responsible for the mek1/MEK1K105R
cells are unable to do so, as previously demonstrated cell chemotaxis and aggregation defects.
using a less quantitative assay (Ma et al., 1997). mek1
null cells are significantly less polarized than wild-type ERK1 Lies Downstream from MEK1 and Exhibits
cells, move considerably more slowly, and exhibit multi- a Chemoattractant-Mediated Relocalization
ple directional changes, probably due to the extension Previous analysis suggested that ERK1 is involved in
of pseudopodia from the sides of the cell, as determined aggregation and/or morphogenesis (Gaskins et al.,
by DIAS computer analysis (Soll and Wessels, 1998). 1994). An erk1 insertional mutant was obtained in a ran-
mek1/MEK1K105R cells showed a similar chemotaxis de- dom mutagenesis screen for Dictyostelium develop-
fect, although not as extreme as that of mek1 null cells mental mutants (http://www-biology.ucsd.edu/others/
dsmith/dictydb.html). Using this information, we made(Figure 1C), suggesting that SUMOylation is required for
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Figure 2. Immunofluorescence Analysis of the Localization of MEK1 and SUMO
(A) Translocation of MEK1-FLAG and HA-DdSUMO to the cell cortex in response to global cAMP stimulation in KAx-3 cells analyzed by
indirect immunofluorescence and DeltaVision deconvolution microscopy. Arrows point to the cortically localized MEK1. Every image represents
deconvolved integration of multiple optical sections through the given cell sample (see Experimental Procedures).
(B) MEK1 translocation to the plasma membrane 10 s after cAMP stimulation. The same pattern of MEK1 localization and translocation was
observed in mek1 null cells expressing MEK1. The lower panel includes nuclear (Hoechst) staining (blue).
(C) Retention of MEK1K105R in the nucleus. In the wild-type KAx-3 cells and in mek1 null cells (data not shown), SUMOylation-deficient mutant
MEK1K105R does not translocate to the cytosol and cell membrane in response to cAMP.
(D) Localization of MEK1 (green) and F-actin (red) in chemotaxing cells. The open arrow shows the direction of cell movement toward the
center of the aggregation stream.
(E) Distribution of MEK1K105R (upper panel) and wild-type MEK1 (lower panel) fluorescence (produced using SoftWorx) throughout representative
cells at 15 s after stimulation. The color scale shows the range of fluorescence intensities in the cell.
(F) Comparison of relative intensities of MEK1 fluorescence in the cell cortex between the wild-type MEK1 and MEK1K105R (n  20; see
Experimental Procedures for the details of the quantitative analysis).
a new erk1 null strain. Figures 1B and 1C show that wild-type and mek1 null cells, using a myc-tagged ERK1
construct that complements the erk1 null cell pheno-erk1 null cells exhibited developmental and chemotaxis
defects similar to those of mek1 null cells (see below), types (data not shown). In contrast to MEK1, ERK1 was
cytosolic rather than nuclear in unstimulated cells. Uponsuggesting that MEK1 and ERK1 are in the same regula-
tory cascade. This conclusion was supported by the chemoattractant stimulation, ERK1 became partially lo-
calized to the cell’s cortex, as does MEK1 (Figure 3B).observation that erk1 null cells expressing constitutively
active MEK1 (MEK1S444E,T448E) exhibited the same pheno- This cortical localization of ERK1 overlaps that of
F-actin. In chemotaxing cells, ERK1 is partially localizedtypes as erk1 null cells (data not shown), consistent
with an epistatic relationship. Further, ERK1 kinase is to the leading edge (Figure 3E). It is, however, absent
in most distal parts of F-actin-enriched membrane pro-activated by chemoattractant stimulation in wild-type
cells with maximal activity at the 15 s time point (Figure trusions. ERK1 did not become visibly cortically local-
ized in mek1 null cells (Figure 3C), indicating a require-3A). No cAMP-stimulated ERK1 activity was observed
in mek1 null cells. These findings are consistent with ment of MEK1 function for ERK1 cortical localization.
These results are consistent with ERK1 cortical localiza-ERK1 lying downstream from MEK1. erk1 null aggre-
gates were slightly larger and the chemotaxis defects tion being associated with its activation by MEK1. (Colo-
calization of ERK1 and MEK1 and ERK1 activity in theappeared to be less severe than in mek1 null cells, sug-
gesting that MEK1 may have functions in addition to the strains expressing MEK1 mutants could not be exam-
ined, as we could not obtain stable transformants over-activation of ERK1.
We examined the subcellular localization of ERK1 in expressing both tagged proteins.)
Regulation of Chemotaxis via MEK1 SUMOylation
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Figure 3. ERK1 Activity and Cortical Localization in Response to cAMP
(A) ERK1 is transiently activated in response to cAMP and MEK1 is required for ERK1 activity. The activity of myc-tagged ERK1 was examined
by immune complex kinase assays (upper panel).
(B and C) MEK1-dependent ERK1 localization in response to global cell stimulation with cAMP. Triple labeling of ERK1 with phalloidin and
nuclei.
(B) Wild-type cells.
(C) mek1 null cells.
(D) Involvement of ERK1 in the feedback control of MEK1 localization. FLAG-MEK1 was expressed in erk1 null cells and its localization and
that of F-actin were examined by immunofluorescence using anti-FLAG and TRITC-labeled phalloidin.
(E) Localization of ERK1 and F-actin in chemotaxing cells. The arrow shows the direction of cell movement.
(F) SUMOylation of MEK1 in erk1 null cells.
To determine whether ERK1 exerts feedback influ- Chemoattractant-Mediated SUMO Conjugation Is
Coupled to MEK1 Activation and Translocationence on the MEK1 subcellular localization, we ex-
pressed MEK1-FLAG in erk1 null cells and examined of MEK1 to the Cell Membrane
To examine the possible relationship between the acti-the subcellular localization of MEK1 and F-actin in re-
sponse to cAMP stimulation. Within 5 s, MEK1 translo- vation of MEK1 and modification by SUMO, we em-
ployed the nonactivatable MEK1 (MEK1S444A,T448A; Ma etcated to the cell cortex, where it colocalized with F-actin
and was still strongly concentrated in the membrane as al., 1997) coexpressed with HA-SUMO. We observed
no SUMOylated forms of MEK1S444A,T448A before or afterlong as 3 min after cAMP stimulation (Figure 3D). The
sustained MEK1 membrane localization in erk1 null cells cAMP stimulation (Figure 4A) and there was no observ-
able accumulation of MEK1S444A,T448A at the cell cortexwas accompanied by an increased and prolonged MEK1
SUMOylation (Figure 3F). Both these results suggest after stimulation (Figure 4C).
To further address the possible role of MEK1 activa-that feedback phosphorylation by ERK1 could be in-
volved in SUMO deconjugation and removal of MEK1 tion in MEK1 SUMOylation, we used constitutively active
MEK1 (MEK1S444E,T448E; Ma et al., 1997) and found that itfrom the plasma membrane.
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Figure 4. SUMOylation and Localization of MEK1S444A,T448A and MEK1S444E,T448E Mutants
(A) MEK1 activation is coupled to SUMOylation. MEK1S444A,T448A is not modified by SUMO. SUMO conjugation was examined as described in
the legend to Figure 1.
(B) MEK1 activation is coupled to SUMOylation. FLAG-MEK1S444E,T448E was expressed in mek1 null cells and examined for SUMOylation as
described above.
(C) Localization of MEK1S444A,T448A and MEK1S444E,T448E mutants. MEK1-phalloidin double labeling was examined as described above.
was constitutively cytosolic, and, in part, present in the and MEK1 deletion mutants showed that the two pro-
teins interact through their N-terminal domains. Incortex of vegetative and unstimulated, aggregation-
competent cells (Figure 4C), colocalizing with F-actin. In MEK1, the interacting domain is located within residues
58–148 (the deletion endpoints), whereas the interactingaddition, MEK1S444E,T448E was constitutively SUMOylated,
and the level of modification did not increase in response region in MIP1 lies between residues 152 and 226 (data
not shown). As depicted in Figure 5D, when FLAG-MEK1to stimulation, although it decreased slightly at later
times (Figure 4B). These results suggest that activation was coexpressed with myc-MIP1, both proteins coim-
munoprecipitated, indicating that they interact in vivo.of MEK1 is linked to its SUMOylation.
The amount of MIP1 that coimmunoprecipitates with
MEK1 was lowest in unstimulated cells and increasedRegulation of MEK1 Function and Localization
through a RING Finger-Containing Interacting Protein with time after cAMP stimulation.
We investigated the potential function of MIP1 by ana-We used a yeast two-hybrid screen with MEK1 as bait
to identify potential MEK1-interacting proteins. One of lyzing the phenotypes of a mip1 null strain (see Experi-
mental Procedures) and wild-type cells overexpressingthe proteins identified, MIP1 (MEK1-interacting protein
1), has a long N-terminal region with a coiled-coil do- MIP1 or expressing the MIP1 RING finger. mip1 null
cells were less polarized in chemoattractant gradients,main, a polyproline domain, and an acidic domain that
lacks sequence homology to known proteins. The MIP1 moved more slowly and with less directionality than
wild-type cells (Figure 1C), and, when plated for multicel-C-terminal domain encodes a C3HC4 RING finger that is
highly homologous to respective domains of E3 ubiquitin lular development, produced large aggregates, some
of which arrest at the mound stage (Figure 5C). Theseligases (Figures 5A and 5B; GenBank accession number
AF446007). A putative nuclear localization sequence lies phenotypes are similar to those of cells expressing con-
stitutively active MEK1S444E,T448E (Ma et al., 1997). In con-immediately N-terminal to the RING finger domain. Pair-
wise yeast two-hybrid interaction assays using MIP1 trast, strains expressing MIP1 or the MIP1 RING finger
Regulation of Chemotaxis via MEK1 SUMOylation
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Figure 5. Primary Structure and Functions of MIP1, a MEK1-Associated Protein
(A) The domain composition and primary structure of MIP1, as predicted by SMART, ProSite, and InterProScan sequence analyses. The
presence of a putative bipartite nuclear localization signal is consistent with MIP1’s nuclear localization. S231 and S376 (bold) are putative
MAP kinase phosphorylation sites.
(B) ClustalW sequence alignment demonstrates that the MIP1 C3HC4 RING finger shares highest homology with BRCA1, COP1, and SP-RING
finger SUMO ligases. Two cysteine residues absent in SP-RING fingers are present in MIP1 and other ubiquitin-specific E3 RING finger
proteins.
(C) The morphology of mip1 null and wild-type KAx-3 cells overexpressing a MIP-RING construct at the aggregation stage of development.
(D) MEK1 and MIP1 associate in vivo as determined by coimmunoprecipitation and Western blot analysis.
domain exhibited chemotaxis and aggregation pheno- MIP1 and MEK1 before and after chemoattractant stim-
ulation in mip1 null cells and wild-type cells overex-types similar to those of mek1 null cells (Figure 5C).
Taken together, these data suggest genetic interactions pressing wild-type MIP1 or the MIP1 RING finger. Myc-
tagged MIP1 is predominantly nuclear in unstimulatedbetween MIP1 and MEK1 consistent with MIP1 exhib-
iting a negative effect on MEK1 function. and stimulated cells (Figure 6D). In contrast to our obser-
vations in wild-type cells, MEK1 is predominantly cyto-To examine functional interactions between MEK1
and MIP1, we studied the subcellular localization of solic in mip1 null cells prior to stimulation, with some
Developmental Cell
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Figure 6. The Effect of MIP1 on MEK1 Ubiquitination, SUMOylation, and Localization
(A) MEK1 SUMOylation was assayed in mip1 null cells as described in the legend to Figure 1.
(B) Localization of MEK1 in mip1 null cells.
(C) The effect of MIP1 overexpression on MEK1 localization.
(D) Localization of MIP1 in wild-type cells. An NLS-RING finger C-terminal fragment of MIP1 also localizes to the nucleus (data not shown),
suggesting that it contains a nuclear targeting signal.
(E and F) The effect of MIP1 on MEK1 ubiquitination. In vivo MEK1 ubiquitination in response to cAMP stimulation was examined by
immunoprecipitation-immunoblot analysis with anti-FLAG and anti-ubiquitin antibodies.
(G) In vitro ubiquitin ligase activity of the MIP1 RING finger. Purified recombinant E1 and E2 were incubated with either MIP1-RING, MIP1-
RING, or the known E3 ligase Hrd1p with ATP and ubiquitin at 25C for 90 min. The control reactions with GST-MIP1-RING and without
individual components (-E1, -ATP, and -ubiquitin) are also shown. Anti-ubiquitin immunoblotting was used for detection.
(H) Quantitation and comparison of nuclear MEK1 fluorescence between the wild-type and mip1 null cells.
of the protein localized to the cell cortex, colocalizing targeting of MEK1. Overexpression studies suggest that
with F-actin (Figures 6B and 6H). an intact, nondisrupted MIP1 RING finger and the whole
Upon cAMP stimulation, the amount of cortically local- MIP1 protein may sequester MEK1 in the nucleus.
ized MEK1 in mip1 null cells increased and appeared to
be highest 15 s after stimulation (Figure 6B). In contrast,
MIP1 Is Required for MEK1 UbiquitinationMEK1 is predominantly nuclear both prior to and after
but Not SUMOylationcAMP stimulation in cells overexpressing wild-type MIP1
As MIP1 directly associates with the region within theor a MIP1 deletion that contains only the MIP1 RING finger
MEK1 N terminus, which contains the SUMO conjuga-(MIP1-RING; Figure 6C). Expression of MIP1 containing a
tion site, we tested whether MIP1 could play a role in thisdisrupted RING finger domain (MIP1C512A,C515A) in mip1 null
modification. As shown in Figure 6A, MEK1 is stronglycells produced normal and large-sized aggregates with
SUMOylated in mip1 null cells, indicating that MIP1 isa partial mound-arrest phenotype, the same phenotype
not directly required for this modification. Together withobserved for mip1 null cells (data not shown). In these
the chemotaxis/aggregation defects of the cells, overex-cells, MEK1 is mostly cytosolic and localizes to the cor-
pressing MIP1 and SUMOylation-deficient MEK1 mu-tex upon cAMP stimulation (data not shown). The recip-
tants, these data argue against the possibility that MIP1rocal patterns of MEK1 distribution between the cytosol
is a MEK1 E3 SUMO ligase. In mip1 null cells, the leveland nucleus in mip1 null compared to MIP1-overex-
pressing cells imply that MIP1 contributes to the nuclear of MEK1 SUMOylation increases after cAMP stimulation
Regulation of Chemotaxis via MEK1 SUMOylation
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and remains elevated as long as 30 min after cAMP Discussion
addition, consistent with a model in which targeting
The MEK1/ERK1 MAP Kinase Cascade Is SpatiallyMEK1 to the nucleus by MIP1 could counteract and limit
and Temporally RegulatedSUMOylation and membrane localization of MEK1.
Previous studies demonstrated that DictyosteliumWhen Western blots of immunoprecipitated FLAG-
MEK1 is required for proper aggregation, morphogene-MEK1 were subjected to the long exposures, in addition
sis, and chemotaxis (Ma et al., 1997). In this manuscript,to the 90 kDa SUMOylated MEK1 band, we observed
we have further defined the mek1 null cell chemotaxisa higher molecular weight “smear” containing MEK1
defect, demonstrating quantitatively that these cells ex-which was more prominent at later time points (3–30
hibit reduced polarity, produce a high frequency ofmin) after chemoattractant stimulation (data not shown).
changes in direction, and move slowly compared toThe pattern suggested that MEK1 might also be ubiquiti-
wild-type cells under our experimental conditions. Fur-nated. When Western blots were probed with an anti-
thermore, we find that the Dictyostelium MAP kinaseubiquitin antibody, we observed a smear, indicating
ERK1 lies downstream from MEK1 to control MEK1-these slower mobility isoforms represent polyubiquiti-
mediated pathways. ERK1 is rapidly and transiently acti-nated MEK1 (Figure 6E). In contrast to the very rapid
vated in response to chemoattractant stimulation andkinetics of MEK1 SUMOylation, the kinetics of MEK1
is dependent on MEK1 function. The fact that ERK1ubiquitination, as determined by the appearance of poly-
activity is maximal at the 15 s time point and then rapidlyubiquitinated MEK1, are extended, with the levels being
decreases suggests that this MAP kinase pathway func-highest at later time points when MEK1 is lost from the
tions in the initial stages of responses to chemoattrac-plasma membrane and reaccumulates in the nucleus.
tant stimulation. As the chemotaxis phenotypes of theAs the MIP1 RING finger domain exhibits strongest
erk1 and mek1 null cells are quite severe, with stronghomology to RING fingers demonstrated to have E3
defects in cell polarity, directionality, and speed, weubiquitin ligase activity (Figure 5B), we examined
suggest that the ERK1/MEK1 MAP kinase cascade con-whether MIP1 was required for MEK1 ubiquitination.
trols multiple effector pathways controlling chemotaxis.When MEK1 ubiquitination was tested in mip1 null cells
We found that, like several PH domain-containing pro-expressing FLAG-MEK1, no ubiquitinated forms of
teins (Chung et al., 2001; Parent and Devreotes, 1999;
MEK1 were observed (Figure 6E). In contrast, overex-
Rickert et al., 2000), both MEK1 and ERK1 transiently
pression of MIP1 (Figure 6F) or expression of the MIP1
localize to the cell cortex in response to chemoattractant
RING finger domain (data not shown) leads to an in-
stimulation and to the leading edge in chemotaxing cells.
creased MEK1 ubiquitination, as compared to the wild- Although it is difficult to compare the kinetics of ERK1
type cells. There was no detectable MEK1 ubiquitination activation and ERK1 and MEK1 membrane localization,
in mip1 null cells expressing the MIP1 RING finger muta- our results suggest that the responses are highly coordi-
tion (MIP1C512A,C515A; Figure 6E, right panel), suggesting nated, consistent with this MAP kinase pathway playing
that an intact RING finger is required for MEK1 ubiquiti- a key role in chemotaxis. However, we cannot exclude
nation. To test whether MIP1 has a RING finger-depen- the possibility that the pathway also has a transcriptional
dent E3 ubiquitin ligase activity, GST-fusion proteins role in regulating the developmental state of the cells.
corresponding to the C-terminal RING finger domain
(MIP1-RING) and the deletion fragment lacking the RING MEK1 SUMOylation Is Required for Its Localization
domain and C terminus of MIP1 (MIP1-RING) were to the Cytosol and Cortex in Response to cAMP
assayed in vitro for self-ubiquitination (Bays et al., 2001). SUMOylation is thought to be involved in the localization
Figure 6G reveals strong E1- and ATP-dependent self- of a variety of cellular proteins, although a direct require-
ubiquitination of MIP1-RING and the yeast ubiquitin E3 ment of SUMOylation for subcellular localization has not
Hrd1p, which was used as a positive control (Figure 6G; been proven in some cases. RanGAP1 was one of the
Bays et al., 2001). MIP1-RING was found to have no first SUMO substrates identified (Matunis et al., 1996).
detectable E3 activity. These results directly demon- Whereas non-SUMOylated RanGAP1 is cytosolic, SU-
strate catalytic ubiquitin ligase activity of MIP1-RING MOylated RanGAP1 localizes to the cytosolic filaments
domain. of the nuclear pore complex, where it interacts with the
We also examined the ubiquitination of non-SUMO- Ran binding protein 2 (RanBP2) and may play a role in
ylated (FLAG-tagged MEK1K105R) and nonactivatable nuclear-cytoplasmic protein transport (Melchior, 2000;
(FLAG-tagged MEK1S444A,T448A) forms of MEK1 expressed Kehlenbach et al., 1999; Azuma and Dasso, 2002).
in mek1 null cells. Although neither form of MEK1 is SUMO conjugation controls the nuclear import of the
SUMOylated, both are ubiquitinated with the kinetics Drosophila transcription factor Bicoid and the NF-B
similar to those of the wild-type MEK1 (i.e., it was in- homolog Dorsal, and the intranuclear accumulation of
creased 1–3 min after cAMP stimulation; data not the papillomavirus E1 protein (see Muller et al., 2001). In
shown). Analysis of cells expressing MEK1K105R suggests S. cerevisiae, the most prominent substrates for SUMO
that ubiquitin is attached to lysine residues other than conjugation are the Septins, cytoskeletal GTP binding
K105R, although we can not exclude the possibility that proteins, which are required for bud growth and cytoki-
Lys105 may also be a site of ubiquitination. Our results nesis, and localize to a ring at the bud neck during
demonstrate that K105R SUMOylation is not required mitosis (Johnson and Blobel, 1999).
to trigger MEK1 ubiquitination, and MEK1 ubiquitination We demonstrate that MEK1 is modified by SUMOyla-
does not require MEK1 activation (i.e., in mek1 null cells tion in response to chemoattractant stimulation with
kinetics that are coincident with MEK1’s translocationexpressing MEK1S444A,T448A).
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Figure 7. Model for the Role of SUMOylation and MIP1 in the Control of MEK1 Localization in Response to Chemoattractant Stimulation
The cartoon shows the activation of distinct components of the MAP kinase pathway and their dynamic relocalization in response to cAMP,
depicted as consecutive steps 1–8 (see text). MEK1 is concentrated in the nucleus prior to stimulation. cAMP stimulation is coupled to the
activation of putative MEKK, which in turn activates MEK1. Activated MEK1 is rapidly SUMOylated and exported out of the nucleus, being
targeted to the cell cortex. ERK1 is activated and recruited to the cell cortex, where we suggest it phosphorylates the set of substrate proteins.
MEK1 is rapidly dephosphorylated and de-SUMOylated and then becomes resequestered in the nucleus, where it associates with MIP1 and
is ubiquitinated. The dual function of MIP1 is nuclear sequestration of MEK1 and E3 ubiquitin ligase activity mediating MEK1 ubiquitination,
both leading to the termination of the signal. Possible alternative models are presented in the Discussion.
from the nucleus to the cytosol and cortex within the significantly after cAMP stimulation. We note that not
all of the MEK1 becomes SUMOylated or localizes tolimits of resolution of our studies. Our mutational analy-
sis indicates that Lys105 is the site of SUMOylation. Our the cortex in response to signaling. It is possible that
this is due to the expected higher-than-wild-type levelsresults show that MEK1K105R predominantly remains in
the nucleus after chemoattractant stimulation. These of MEK1 and MIP1 that are expressed in our stably
transformed strains. This results from the high copydata suggest that SUMOylation is required for exit from
the nucleus and/or localization to the cell’s cortex with number of the tandemly repeated integrated vector (Nel-
len and Firtel, 1985). Higher-than-wild-type level MEK1SUMOylation functioning as part of a nuclear export
and/or cortical localization signal. The connection be- in these strains may saturate the SUMOylation or up-
stream activation machinery, possibly resulting in a lim-tween SUMOylation and nucleocytoplasmic transport is
further supported by the demonstration that RanBP2, a ited fraction of the MEK1 being activated and/or SU-
MOylated. It is also possible that MEK1 may haveregulator of nuclear protein import and export (Kehlen-
bach et al., 1999), exhibits E3 SUMO ligase activity nuclear functions and only a portion of MEK1 is SUMO-
ylated and localizes to the cortex.(Pichler et al., 2002; Azuma and Dasso, 2002). We cannot
exclude an alternate model in which MEK1 is in a dy- Our data suggest the regulatory pathway presented in
Figure 7. Although other scenarios are possible, we pro-namic nucleocytoplasmic equilibrium that is slanted in
the direction of nuclear localization in unstimulated cells pose that nuclearly localized MEK1 is activated, possibly
in the nucleus, by a yet-to-be identified upstream kinaseand shifted to a cytosolic/cortical localization with SU-
MOylation, possibly inhibiting MEK1 transport into the leading to its SUMOylation, coupled to transport to the
cytosol, and localization to the cell cortex in responsenucleus. Although we cannot formally exclude this
model, we do not favor it because of the localization to global stimulation and to the leading edge in chemo-
taxing cells. ERK1 is recruited and activated by MEK1properties of other MEK1 and MIP1 mutant proteins.
We further demonstrate that MEK1S444A,T448A, which and also localizes to the cell’s cortex. As some MEK1
is cytoplasmic in unstimulated cells, we cannot excludecannot be activated, is not SUMOylated and remains
nuclear, whereas constitutively active MEK1S444E,T448E is the possibility that part of the MEK1 that localizes to the
cortex comes from this cytoplasmic pool. Although thefound predominantly in the cytosol and on the plasma
membrane, even in vegetative and aggregation-compe- mechanism of MEK1 inactivation is unknown, the obser-
vation that constitutively active MEK1S444E,T448E is cy-tent unstimulated cells. As a significant fraction (but not
all) of MEK1S444E,T448E is constitutively SUMOylated, we tosolic and constitutively SUMOylated while inac-
tive MEK1S444A,T448A is nuclear suggests that the first stepsuggest that activation of MEK1 is the signal that leads
to its SUMOylation. In mip1 null cells, the major portion in MEK1 adaptation may be a dephosphorylation of the
MEK1 activation loop, followed by deSUMOylation,of MEK1 is cytosolic in unstimulated cells with a portion
being SUMOylated. The level of SUMO-MEK1 increases which leads to the loss of cortical localization and re-
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transport to the nucleus. As MEK1 is SUMOylated for lated by differential SUMOylation and ubiquitination. As
MAP kinase pathways are also required for the cell mi-an extended time in erk1 null cells, it is possible that a
feedback phosphorylation by ERK1 leads to de-SUMO- gration of fibroblasts (Giroux et al., 1999; Yujiri et al.,
2000), there may be a commonality of function of MAPylation. The kinetics of MEK1 ubiquitination suggest that
the process is activated or increases in rate in response kinase pathways in this evolutionarily conserved cellular
response. Interestingly, mammalian MEK1 and MEK2to cAMP stimulation. Our cartoon depicts this occurring
in the nucleus, as MIP1 is predominantly nuclear, and and MEKs in yeast, plants, and fungi have sequences
in their N termini fitting the I/LKXE(D) consensus forMIP1 is required for MEK1 ubiquitination. MEK1S444E,T448E
is also ubiquitinated (our unpublished observations), SUMO conjugation (see Supplemental Table S1 at http://
www.developmentalcell.com/cgi/content/full/2/6/which may occur in the nucleus, as not all MEK1S444E,T448E
is cytosolic. 745/DC1), but it is unknown whether these proteins are
SUMOylated in response to signaling and whether this
may regulate their function. It is intriguing that one ofMIP1 Is a Putative Ubiquitin E3 Ligase that Controls
these motifs in MEK1 and MEK2 is the part of well-MEK1 Localization and Ubiquitination
characterized, leucine-rich MEK nuclear export signalOur combined genetic and biochemical evidence sug-
(NES). Nishida and coworkers (Fukuda et al., 1996, 1997)gests that MIP1 is a MEK1 ubiquitin E3 ligase. The re-
found that disruption of this motif by mutagenesis pre-combinant RING finger of MIP1, which is highly homolo-
vents the CRM1-mediated translocation of MEK1 out ofgous to known RING finger E3 ligases, shows strong
the nucleus. The absence of an obvious NES in Dictyo-ubiquitin ligase activity in vitro; mip1 null cells do not
stelium MEK1 may explain why it is concentrated in theexhibit MEK1 ubiquitination, whereas MEK1 is hyperubi-
nuclei of nonstimulated cells and why it is not constitu-quitinated in cells overexpressing MIP1 or the MIP1
tively excluded from the nuclei, as occurs with mamma-RING finger domain; MIP1 and MEK1 directly associate
lian MEK1. MEK1 SUMOylation could represent an an-in a yeast two-hybrid assay and interact in vivo as deter-
cient conserved mechanism controlling subcellularmined by coimmunoprecipitation. The in vivo associa-
localization of these proteins.tion is strongest several minutes after chemoattractant
stimulation, coincident with the kinetics of ubiquitina-
Experimental Procedurestion. However, we cannot exclude the possibility that
the effect of MIP1 on MEK1 is indirect, and MIP1 could
Molecular Biology
function as E3 ligase for an unknown protein in the same MIP1 (GenBank accession number AF446007) was identified in a
complex. yeast two-hybrid screen, using the full-length MEK1 as bait. To
knock out MIP1, a BamHI linker was inserted at the PvuII site of theWe show that overexpression of MIP1 leads to the
MIP1 sequence and a fragment containing a blasticidin-resistant Bsrretention of MEK1 in the nucleus after chemoattractant
gene cassette. The complete DdSUMO gene sequence (GenBankstimulation and constitutive ubiquitination. In agreement
accession number AF446008) was identified by using the Dictyoste-with the observed aggregation defect, it is possible that
lium genome BLAST search. ORFs encoding MIP1 and DdSUMO
overexpression of MIP1 is sufficient to prevent MEK1’s were amplified by PCR using a Dictyostelium cDNA library and sub-
activation, SUMOylation, and transport to the cytosol. cloned into Dictyostelium expression vectors (Ma et al., 1997). Mu-
tants were obtained using the Transformer kit (Clontech) or theWe observe a much lower level of MEK1 protein in MIP1-
QuickChange mutagenesis kit. FLAG-, myc-, and HA-tagged se-overexpressing cells than in wild-type cells. In contrast,
quences were added in-frame by PCR. The sequence of amplifiedin mip1 null cells and cells expressing MIP1C512A,C515A,
DNA was confirmed by sequencing.the steady-state levels of MEK1 protein are significantly
higher, even though the levels of MEK1 transcripts in
Materials
all these strains are the same (data not shown). This Protein A and G Sepharose were obtained from Sigma and Santa
finding suggests that MEK1 protein may exhibit a rapid Cruz Biotechnology. TRITC-phalloidin, myelin basic protein (MBP),
protein kinase inhibitors, and protease inhibitors were from Sigma.rate of turnover in MIP1-overexpressing cells, possibly
Recombinant human E1, E2 (Ubc4), ubiquitin, and Hrd1p were gen-through an increased level of ubiquitination and degra-
erous gifts from R. Hampton (UCSD).dation.
Anti-FLAG monoclonal antibody (M2) was from Sigma. AntibodiesMammalian MEKK1 has an E3 ubiquitin ligase RING
to the myc tag were obtained from Invitrogen and Santa Cruz. Anti-
finger domain, suggesting that MEKK1 mediates the HA (12CA5) antibodies were from Roche and Santa Cruz. Anti-
degradation of a subset of cellular proteins. We pre- human SUMO1 antibodies were from Zymed and Santa Cruz. Goat
anti-mouse and anti-rabbit FITC- and TRITC-conjugated antibodiesviously demonstrated that the Dictyostelium MEKK,
were from Sigma and Jackson ImmunoResearch. Anti-mouse andMEKK, which has an F box and WD40 repeats as part
anti-rabbit HRP-conjugated antibodies were from Amersham Bio-of the protein and is important in controlling cell fate
sciences.decisions in Dictyostelium, is regulated through prefer-
ential degradation in a cell type-specific manner (Chung
Cell Biology and Biochemistry
et al., 1998). Furthermore, the presence of the RING The Dictyostelium strains used and methods employed have been
domain in yeast Ste5 suggests that one or more compo- previously described (Ma et al., 1997). Chemotaxis assays and im-
age acquisition were carried out as described previously (Chungnents of the pheromone-activated MAP kinase cascade
and Firtel, 1999). Cell movement and cell shape were analyzed usingmay be ubiquitinated. It is possible that one method of
DIAS software (Solltech; Wessels and Soll, 1998).downregulating some MAP kinase signaling pathways
To measure ERK1 kinase activity, cells were assayed as describedis through ubiquitination.
for Akt kinase activity (Meili et al., 1999), except that myc-ERK1
In this manuscript, we have provided the evidence was immunoprecipitated using anti-myc antibody, with MBP as the
that a MAP kinase pathway that is essential for proper substrate. SDS-PAGE and immunoblotting were carried out using
standard procedures with the ECL kit (Amersham) for detection.development and chemotaxis in Dictyostelium is regu-
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Recombinant GST MIP1-RING and MIP1-RING fusion proteins Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Ya-
nagida, M., and Nishida, E. (1997). CRM1 is responsible for intracel-were purified using glutathione agarose and used in an in vitro self-
ubiquitination assay with human recombinant E1 and E2 (Ubc4), as lular transport mediated by the nuclear export signal. Nature 390,
308–311.described (Bays et al., 2001).
For immunofluorescence microscopy, images were acquired with Gaskins, C., Maeda, M., and Firtel, R. (1994). Identification and func-
a DeltaVision deconvolution microscope system in the UCSD Cancer tional analysis of a developmentally regulated extracellular signal-
Center Digital Imaging Core. Data sets were deconvolved and ana- regulated kinase gene in Dictyostelium discoideum. Mol. Cell. Biol.
lyzed using SoftWorx software (Applied Precision; Agard et al., 1989) 10, 6996–7012.
on a Silicon Graphics Octane workstation. Giroux, S., Tremblay, M., Bernard, D., Cardin-Girard, J., Aubry, S.,
MEK1 fluorescence intensities of deconvolved images were ac- Larouche, L., Rousseau, S., Huot, J., Landry, J., Jeannotte, L., and
quired in equal rectangular boxes at three positions (nucleus, cyto- Charron, J. (1999). Embryonic death of Mek1-deficient mice reveals
sol, and cell membrane) along radial axes connecting the areas of a role for this kinase in angiogenesis in the labyrinthine region of
measurement and analyzed using SoftWorx. Relative intensities of the placenta. Curr. Biol. 9, 369–372.
fluorescence in the cell membrane and nuclei shown on the graphs
Hochstrasser, M. (2001). Sp-Ring for SUMO. New functions bloomwith respective standard deviations represent average values of 20
for a ubiquitin-like protein. Cell 106, 735–744.to 25 measurements and are determined as (IMEMBRANE / [IMEMBRANE 
Johnson, E., and Blobel, G. (1999). Cell cycle-regulated attachmentICYTOSOL  INUCLEUS]) and (INUCLEUS / [IMEMBRANE  ICYTOSOL  INUCLEUS]), respec-
of the ubiquitin-related protein SUMO to the yeast septins. J. Celltively. The paired two-sample t test was used for the statistical
Biol. 147, 981–994.analysis of quantitative data.
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